Antiviral and immunomodulatory effects of a novel bacterial exopolysaccharide of shallow marine vent origin

Journal of Applied Microbiology

Volumn 116, Issue 4, 2014, Pages 1028-1034

  Gugliandolo, C ^a   Spano A ^a   Lentini, V ^a   Arena, A ^b   Maugeri, T L ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Bacillus; Exopolysaccharide; Viruses

Indexed keywords

BACILLI; BACTERIOLOGY; CELLS; CYTOLOGY; HOT SPRINGS; METABOLITES; VENTS;

ANTI-VIRAL EFFECTS; BACILLUS LICHENIFORMIS; CYTOKINES; EXOPOLYSACCHARIDES; HALOALKALIPHILIC; HERPES SIMPLEX VIRUS TYPE-2; IMMUNOMODULATORY EFFECTS; PERIPHERAL BLOOD MONONUCLEAR CELLS; SHALLOW MARINE; THERMOPHILIC BACILLI;

VIRUSES;

ALPHA INTERFERON; EXOPOLYSACCHARIDE; EXOPOLYSACCHARIDE EPS1; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; BACTERIAL POLYSACCHARIDE; CYTOKINE; EXOPOLYSACCHARIDE, BACILLUS; IMMUNOLOGIC FACTOR;

EXOPOLYMER; GENETIC ANALYSIS; IMMUNE RESPONSE; ISLAND; MARINE ECOSYSTEM; MICROBIAL ACTIVITY; MICROBIAL COMMUNITY; POLYSACCHARIDE; VIRAL DISEASE;

ANTIVIRAL ACTIVITY; ARTICLE; BACILLUS LICHENIFORMIS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY TEST; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HYDROTHERMAL VENT; IMMUNOMODULATION; ITALY; LIMULUS LYSATE TEST; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SUPERNATANT; TH1 CELL; TH2 CELL; VIRUS REPLICATION; BACILLUS; BIOSYNTHESIS; DRUG EFFECTS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MONONUCLEAR CELL; TOXICITY; VIROLOGY;

ITALY;

BACILLUS (BACTERIUM); BACILLUS LICHENIFORMIS; BACTERIA (MICROORGANISMS); HUMAN HERPESVIRUS 2;

ANTIVIRAL AGENTS; BACILLUS; CYTOKINES; HERPESVIRUS 2, HUMAN; HUMANS; HYDROTHERMAL VENTS; IMMUNOLOGIC FACTORS; ITALY; LEUKOCYTES, MONONUCLEAR; POLYSACCHARIDES, BACTERIAL;

EID: 84900371873     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/jam.12422     Document Type: Article

References (46)

1. Arena, A., Maugeri, T.L., Pavone, B., Iannello, D., Gugliandolo, C. and Bisignano, G. (2006) Antiviral and immunomodulatory effect of a novel exopolysaccharide from a marine thermotolerant Bacillus licheniformis. Int Immunopharmacol 6, 8-13.
2. Arena, A., Gugliandolo, C., Stassi, G., Pavone, B., Iannello, D., Bisignano, G. and Maugeri, T.L. (2009) An exopolysaccharide produced by Geobacillus thermodenitrificans strain B3-72: antiviral activity on immunocompetent cells. Immunol Lett 123, 132-137.
3. Arena, A., Bisignano, C., Stassi, G., Mandalari, G., Wickham, M.S.J. and Bisignano, G. (2010) Immunomodulatory and antiviral activity of almond skins. Immunol Lett 132, 18-23.
4. Boulanger, M.J., Chow, D.C., Breynova, E., Martick, M., Stanford, G. and Nocholas, J. (2004) Molecular mechanisms for viral mimicry of a human cytokine: activation of gp 130 by HHV-8 interleukin-6. J Mol Biol 335, 641-654.
5. Boyd, M.R., Gustafson, K., McMahon, J. and Shoemaker, R. (1996) Discovery of cyanovirin-N, a novel HIV-inactivating protein from Nostoc ellipsosporum that targets viral gp120. Int Conf AIDS 11, 71.
6. Cescutti, P., Kallioinen, A., Impallomeni, G., Toffanin, R., Pollesello, P., Leisola, M. and Eerikäinen, T. (2005) Structure of the exopolysaccharide produced by Enterobacter amnigenus. Carbohydr Res 340, 439-447.
7. Freitas, F., Alves, V.D. and Reis, M.A.M. (2011a) Advances in bacterial exopolysaccharides: from production to biotechnological applications. Trends Biotechnol 29, 388-398.
8. Freitas, F., Alves, V.D., Torres, C.A.V., Cruz, M., Sousa, I., Melo, M.J., Ramos, A.M. and Reis, M.A.M. (2011b) Fucose-containing exopolysaccharide produced by the newly isolated Enterobacter strain A47 DSM23139. Carbohydr Polymers 1, 159-165.
9. Fujioka, N., Akazawa, R., Ohashi, K., Fujii, M., Ikeda, M. and Kurimoto, M. (1999) Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. J Virol 73, 2401-2409.
10. García-Satre, A. and Biron, C.A. (2006) Type 1 interferons and the virus-host relationship: a lesson in Détente. Science 312, 879-882.
11. Guézennec, J.G. (2002) Deep-sea hydrothermal vents: a new source of innovative bacterial exopolysaccharides of biotechnological interest? J Ind Microbiol Biotechnol 29, 204-208.
12. Guézennec, J.G. (2003) From extreme environments to biologically active exopolysaccharides. Commun Agric Appl Biol Sci 68, 227-234.
13. Guézennec, J.G., Herry, J.M., Kouzayha, A., Bachere, E., Mittelman, M.W. and Bellon Fontaine, M.N. (2012) Exopolysaccharides from unusual marine environments inhibit early stages of biofouling. Int Biodeterior Biodegradation 66, 1-7.
14. Gugliandolo, C., Lentini, V., Spanò, A. and Maugeri, T.L. (2012) New bacilli from shallow hydrothermal vents of Panarea Island (Italy) and their biotechnological potential. J Appl Microbiol 112, 1102-1112.
15. Gustafson, K.R., Roman, M. and Fenical, W. (1989) The macrolactins, a novel class of antiviral and cytotoxic macrolides from a deep-sea marine bacterium. J Am Chem Soc 111, 7519-7524.
16. Kumar, A.S., Mody, K. and Jha, B. (2007) Bacterial exopolysaccharides-a perception. J Basic Microbiol 47, 103-117.
17. Laurienzo, P. (2010) Marine polysaccharides in pharmaceutical applications: an overview. Mar Drugs 8, 2435-2465.
18. Lentini, V., Gugliandolo, C. and Maugeri, T.L. (2007) Identification of enzyme-producing thermophilic bacilli isolated from marine vents of Eolian Islands (Italy). Ann Microbiol 57, 355-361.
19. Liu, C., Lu, J., Lu, L., Liu, Y., Wanga, F. and Xiao, M. (2010) Isolation, structural characterization and immunological activity of an exopolysaccharide produced by Bacillus licheniformis 8-37-0-1. Bioresour Technol 101, 5528-5533.
20. Mancuso-Nichols, C., Guézennec, J. and Bowman, J.P. (2005) Bacterial exopolysaccharides from extreme marine environments with special consideration of the southern ocean, sea ice and deep-sea hydrothermal vents: a review. Mar Biotechnol 7, 253-271.
21. Marshall, J.D., Secrist, H., DeKruyoff, R.H., Wolf, S.F. and Umetsu, D.T. (1995) IL-12 inhibits the production of IL-4 and IL-10 in allergen specific human CD4 T lymphocytes. J Immunol 155, 111-117.
22. Matsuda, M., Worawattanamateekul, W. and Okutani, K. (1992) Simultaneous production of muco and sulfated polysaccharides by marine Pseudomonas. Nippon Suisian Gakk 58, 1735-1741.
23. Matsuda, M., Yamori, T., Naitoh, M. and Okutani, K. (2003) Structural revision of sulfated polysaccharide B-1 isolated from a marine Pseudomonas species and its cytotoxic activity against human cancer cell lines. Mar Biotechnol 5, 13-19.
24. Maugeri, T.L., Gugliandolo, C., Caccamo, D. and Stackebrandt, E. (2001) A polyphasic taxonomic study of thermophilic bacilli from shallow, marine vents. Syst Appl Microbiol 24, 451-468.
25. Maugeri, T.L., Gugliandolo, C., Caccamo, D., Panico, A., Lama, L., Gambacorta, A. and Nicolaus, B. (2002a) A halophilic thermotolerant Bacillus isolated from a marine hot spring able to produce a new exopolysaccharide. Biotechnol Lett 24, 515-519.
26. Maugeri, T.L., Gugliandolo, C., Caccamo, D. and Stackebrandt, E. (2002b) Three novel halotolerant and thermophilic Geobacillus strains from shallow marine vents. Syst Appl Microbiol 25, 450-455.
27. Maugeri, T.L., Lentini, V., Gugliandolo, C., Italiano, F., Cousin, S. and Stackebrandt, E. (2009) Bacterial and archaeal populations at two shallow hydrothermal vents of Panarea Island (Eolian Islands, Italy). Extremophiles 13, 199-212.
28. Maugeri, T.L., Lentini, V., Gugliandolo, C., Cousin, S. and Stackebrandt, E. (2010a) Microbial diversity at a hot shallow thermal vent in the Southern Tyrrhenian Sea (Italy). Geomicrobiol J 27, 380-390.
29. Maugeri, T.L., Bianconi, G., Canganella, F., Danovaro, R., Gugliandolo, C., Italiano, F., Lentini, V., Manini, E. et al. (2010b) Shallow hydrothermal vents in the southern Tyrrhenian Sea. Chem Ecol 26, 285-298.
30. Mogensen, T.H., Melchjorsen, J., Malmgaard, L., Casola, A. and Paludan, S.R. (2004) Suppression of proinflammatory cytokine expression by herpes simplex virus type 1. J Virol 78, 5883-5890.
31. Mosmann, T. (1989) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55-63.
32. Nicolaus, B., Panico, A., Manca, M.C., Lama, L., Gambacorta, A. and Maugeri, T.L. (2000) A thermophilic Bacillus isolated from an Eolian shallow hydrothermal vent, able to produce exopolysaccharides. Syst Appl Microbiol 23, 426-432.
33. Nicolaus, B., Schiano Moriello, V., Maugeri, T.L., Gugliandolo, C. and Gambacorta, A. (2003) Bacilli from shallow Mediterranean marine vents producers of exopolysaccharides. Recent Res Devel Microbiol 7, 197-208.
34. Nicolaus, B., Kambourova, M. and Oner, E.T. (2010) Exopolysaccharides from extremophiles: from fundamentals to biotechnology. Environ Technol 31, 1145-1158.
35. Okutani, K. (1984) Antitumor and immunostimulant activities of polysaccharide produced by a marine bacterium of the genus Vibrio. Bull Jpn Soc Sci Fish 50, 1035-1037.
36. Péterszegi, G., Fodil-Bourahla, I., Robert, A.M. and Robert, L. (2003) Pharmacological properties of fucose. Applications in age-related modifications of connective tissues. Biomed Pharmacother 57, 240-245.
37. Poli, A., Anzelmo, G. and Nicolaus, B. (2010) Bacterial exopolysaccharides from extreme habitat: production, characterization and biological activities. Mar Drugs 8, 1779-1802.
38. Rasmussen, S.B., Sørensen, L.N., Malmgaard, L., Ank, N., Baines, J.D. and Chen, Z.J. (2007) Type I interferon production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems. J Virol 81, 13315-13324.
39. Spanò, A., Gugliandolo, C., Lentini, V., Maugeri, T.L., Anzelmo, G., Poli, A. and Nicolaus, B. (2013) A novel EPS-producing strain of Bacillus licheniformis isolated from a shallow vent off Panarea Island (Italy). Curr Microbiol 67, 21-29.
40. Takeda, K., Tsutsui, H., Yoshimoto, T., Adachi, O., Yoshida, N. and Kishimoto, T. (1998) Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8, 383-390.
41. Umezawa, H.Y., Okami, Y., Kurasawa, S., Ohnuki, T. and Ishizuka, M. (1983) Marinactan, antitumor polysaccharide produced by marine bacteria. J Antibiot 5, 471-477.
42. Vanhooren, P.T. and Vandamme, E.J. (1999) L-Fucose: occurrence, physiological role, chemical, enzymatic and microbial synthesis. J Chem Technol Biotechnol 74, 479-497.
43. Vo, T.-S., Ngo, D.-H., Ta, Q.V. and Kim, S.-K. (2011) Marine organisms as a therapeutic source against herpes simplex virus infection. Eur J Pharm Sci 44, 11-20.
44. Weiner, R.M. (1997) Biopolymers from marine prokaryotes. Trends Biotechnol 15, 390-394.
45. Weiner, R., Langille, S. and Quintero, E. (1995) Structure, function and immunochemistry of bacterial exopolysaccharides. J Ind Microbiol Biotechnol 15, 339-346.
46. Yasuhara-Bell, J. and Lu, Y. (2010) Marine compounds and their antiviral activities. Antiviral Res 86, 231-240.